Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Perphenazine (Trilafon) is a phenothiazine derivative and a dopamine antagonist with antiemetic and antipsychotic properties.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
50 mg | In stock | $ 29.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 50.00 |
Description | Perphenazine (Trilafon) is a phenothiazine derivative and a dopamine antagonist with antiemetic and antipsychotic properties. |
Targets&IC50 | D2L Receptor:3.4 nM, 5-HT2Areceptor:5.6 nM, Dopamine receptor D2/D3:0.765/0.13 nM, Alpha-1A adrenergic receptor:10 nM, Histamine H1 receptor:8 nM |
In vitro | Perphenazine is a relatively high potency phenothiazine that blocks dopamine 2 (D2) receptors predominantly but also may possess antagonist actions at histamine 1 (H1) and cholinergic M1 and alpha 1 adrenergic receptors in the vomiting center leading to reduced nausea and vomiting[1]. Perphenazine induces cell death and mitochondrial damage, also caspase-3 activation and a decrease in cellular ATP level. The cell death induced by perphenazine is partially suppressed by antioxidant but not by pan-caspase inhibitor[4]. Perphenazine in concentration range from 0.0001 to 0.01 μM did not have any significant effect on melanocytes viability. The treatment of cells with the drug in higher concentrations results in the loss in cell viability in a concentration-dependent manner. The value of EC50 for perphenazine is 2.76 μM. Perphenazine in concentrations of 1.0 and 3.0 μM also decreases the tyrosinase activity, as well as melanin content[5]. |
In vivo | Perphenazine is well absorbed after oral administration. The time to peak after oral administration is 1-3 hours with the time to peak of the metabolite 7-hydroxyperphenzaine 2-3 hours. Perphenazine has a half-life elimination of 9-12 hours and its metabolite 7-hydroxyperphenazine of 10-19 hours[1]. Perphenazine has been used as a psychotropic drug for several decades in therapy of certain psychiatric disorders. In rat isolated heart, perphenazine significantly prolongs the QT interval and triggers arrhythmias in considerable numbers both at the high concentration and at the therapeutical concentration. This proarrhythmogenic effect is observed even after repeated exposure to perphenazine[3]. |
Cell Research | cells are plated on 96-well plates and treated with drugs for various time periods. Then the cells are incubated with MTS assay reagent for 1 hr. The plates are then read at 490 nm using a microplate reader.(Only for Reference) |
Synonyms | Perphenazin, Etaperazine, Trilafon |
Molecular Weight | 403.97 |
Formula | C21H26ClN3OS |
CAS No. | 58-39-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 74 mg/mL (183.18 mM)
DMSO: 67 mg/mL(165.9 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Perphenazine 58-39-9 GPCR/G Protein Immunology/Inflammation Neuroscience Histamine Receptor Dopamine Receptor 5-HT Receptor CaMK Adrenergic Receptor Autophagy inhibit Serotonin Receptor anti-cancer dermatitis U-87 MG cells Apoptosis Inhibitor lysosome Perphenazin liver injury hepatotoxicity Mental disease Etaperazine Beta Receptor inflammation Trilafon 5-hydroxytryptamine Receptor inhibitor